SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007783
Filing Date
2016-08-09
Accepted
2016-08-09 16:01:46
Documents
75
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aegr-20160630x10q.htm 10-Q 2473603
2 EX-10.7 aegr-20160630ex107228ba9.htm EX-10.7 43799
3 EX-31.1 aegr-20160630ex3118bd5c9.htm EX-31.1 12484
4 EX-31.2 aegr-20160630ex312b007ca.htm EX-31.2 12233
5 EX-32.1 aegr-20160630ex32124103b.htm EX-32.1 9164
6 EX-32.2 aegr-20160630ex3227d8200.htm EX-32.2 8462
7 GRAPHIC aegr20160630ex107228ba9001.jpg GRAPHIC 9418
  Complete submission text file 0001558370-16-007783.txt   8092691

Data Files

Seq Description Document Type Size
8 EX-101.INS aegr-20160630.xml EX-101.INS 1661151
9 EX-101.SCH aegr-20160630.xsd EX-101.SCH 48471
10 EX-101.CAL aegr-20160630_cal.xml EX-101.CAL 60835
11 EX-101.DEF aegr-20160630_def.xml EX-101.DEF 159887
12 EX-101.LAB aegr-20160630_lab.xml EX-101.LAB 402130
13 EX-101.PRE aegr-20160630_pre.xml EX-101.PRE 337773
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 161817796
SIC: 2834 Pharmaceutical Preparations